Small Molecule Discovery at Novel Drug Targets

Orphagen Pharmaceuticals does translational research, discovering new classes of small molecule drugs to promising but previously unexplored drug targets. Our goal is to deliver revolutionary drugs to treat diverse, chronic diseases in collaboration with partners. 

Orphagen has identified novel approaches to several orphan indications, including retinitis pigmentosa, Cushing’s syndrome and adrenocortical cancer. The pharmaceutical industry recognizes the advantages of commercializing an orphan drug because of shorter clinical development times and more generous reimbursement.


81sc

Orphagen Pharmaceuticals


Attend SDEE Events Donate | Sponsor SDEE Become a Member

Connect with SDEE

Sign Up for SDEE Newsletter


SDEE GOLD SPONSORS

Takeda San Diego

SDEE SILVER SPONSORS

Barney and Barney TriNet

SDEE BRONZE SPONSORS

Knobe Martens Duane Morris MaxCyte

SDEE is a nonprofit 501(c)(3) organization founded by local San Diego entrepreneurs
in order to provide a voice for the early stage start-up, to support new entrepreneurs and their companies,
and to sponsor networking and educational events
to help develop the skills necessary to bring funding, business, and jobs to the San Diego area.

© 2015 San Diego Entrepreneurs Exchange. All Rights Reserved